Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD6 | Q9BV23 | 14/20 | 0.69 |
| ▸ | MGLL | Q99685 | 9/20 | 0.69 |
| ▸ | PLA2G7 | Q13093 | 5/20 | 0.57 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15100761 | 0.94 | ABHD6 (0.77) | ABHD6MGLLPLA2G7 | |
| SCHEMBL20408675 | 0.84 | MGLL (0.59) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL15100763 | 0.83 | MGLL (0.79) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL26079559 | 0.82 | MGLL (0.57) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL21868779 | 0.82 | CACNA2D1 (0.48) | ABHD6MGLLCACNA2D1CACNA1BCACNB1 | |
| SCHEMBL15100884 | 0.82 | MGLL (1.00) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL16744460 | 0.81 | MGLL (0.76) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL22365053 | 0.76 | MGLL (0.68) | ABHD6MGLLPLA2G7CACNA2D1CACNA1B | |
| SCHEMBL16744475 | 0.76 | ABHD6 (0.56) | ABHD6MGLLPLA2G7 | |
| SCHEMBL15101001 | 0.76 | CNR1 (0.49) | ABHD6MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3326627-A1 | CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME | Abide Therapeutics, Inc. (US) | 2018-05-30 | — | — | EP | disclosed |